Nikolaos Takmopoulos
@Ajovista, Llc
Latest period2024 - Q3ReportedManaged Assets$23.402MTotal holdings112
Assets growth rate-32.52%Assets growth rate (2-Q avg)-19.29%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Ajovista, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 112 positions.
Assets under management
The assets under management (AUM) of Ajovista, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 23.402M in assets, with a quarterly growth rate of -32.52% and a 2-quarter average growth rate of -19.29%. The portfolio is managed by Nikolaos Takmopoulos, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
BEKEKe Hldgs Inc
| 8.98% | $2.1M 105,472 shares@ $19.92 avg price | New Position |
QFINQifu Technology Inc
| 6.95% | $1.626M 54,560 shares@ $29.82 avg price | New Position |
JDJd.com Inc
| 5.31% | $1.241M 31,023 shares@ $40.0 avg price | New Position |
BABAAlibaba Group Hldg Ltd
| 4.01% | $937,464 8,834 shares@ $106.12 avg price | New Position |
VALEVale S A
| 1.52% | $353,892 30,299 shares@ $11.68 avg price | New Position |
NECBNortheast Cmnty Bancorp Inc
| 1.4% | $326,552 12,346 shares@ $26.46 avg price | New Position |
PNTGPennant Group Inc
| 1.29% | $301,844 8,455 shares@ $35.71 avg price | New Position |
OSPNOnespan Inc
| 1.27% | $296,293 17,774 shares@ $16.68 avg price | New Position |
ADPTAdaptive Biotechnologies Cor
| 1.24% | $288,102 56,270 shares@ $5.12 avg price | New Position |
PAHCPhibro Animal Health Corp
| 1.23% | $286,927 12,741 shares@ $22.52 avg price | New Position |